Author Archive: Jeremy Parkinson
Bayer To Sell Some Units To BASF, Paving The Way For Monsanto Megadeal
Shares of Monsanto (MON) jumped in morning trading after Bayer (BAYRY) agreed to sell parts of its seeds and herbicides businesses to BASF (BASFY), paving the way for the Roundup maker to be acquired by the German conglomerate for $66B. BAYER SELLING UNITS FOR EUR5.9B: Bayer (BAYRY) said in a statement that it has agreed […]
Swing Trading Strategy – Friday, October 13
My Swing Trading Approach I’m nearing a point where I want to see price action move out of the recent price coil before getting any more aggressive on this market. As always, I’ll look for opportunities where appropriate, to book profits and move up stop-losses. Indicators VIX – Slight uptick, still below 10 at 9.91. But […]
Alaska Airlines Major Trend Break
Even with market indexes making lifetime highs every single day (with the notable exception of Saturday and Sunday), including the Dow Transports, I thought I’d point this out: The above is Alaska AIrlines (ALK), and as you can see, it broken its long term trendline. Here’s a closer look. I’m already short it, with that […]
Gold Miners’ Q3’17 Preview
With the third quarter’s earnings season now underway, the gold miners will soon join in and report their latest results. No data is more highly anticipated by investors, for good reason. Quarterly reports dispel the dense fogs of herd sentiment that usually obscure gold stocks, revealing their operations’ underlying fundamental realities. Q3’17’s upcoming results are […]
Retail Storms
Retail sales were added in September 2017 due to the hurricanes in Texas and Florida (and the other states less directly impacted). On a monthly, seasonally-adjusted basis, retail sales were up a sharp 1.7% from August. The vast majority of the gain, however, was in the shock jump in gasoline prices. Retail sales at gasoline […]
Teva Maneuvers To Match 30% Discounts For Generic Copaxone
The major question surrounding Teva (TEVA) is how much Mylan’s (MYL) generic Copaxone will impact Copaxone sales. The answer to that question began to materialize after Mylan offered 25% – 30% discounts on generic Copaxone: Just how much Mylan’s generic of 40-mg multiple sclerosis blockbuster Copaxone ends up hurting Teva depends on the knockoff’s pricing, […]
Goldman Lowers December Rate Hike Odds After CPI Miss
Having been ahead of the market anywhere between 4 and 8 weeks as consensus caught up to Goldman’s view on December rate hike odds, which for months were materially higher than what the market implied, Jan Hatzius quietly emerged as one of the very rare Fed whisperers (this year) who has actually gotten what the […]
U.S. Dollar Drops, 2017 Down-Trend Continues As Inflation Disappoints
It was just a week ago that an abysmal NFP print helped to push the Dollar back into its 2017 down-trend. And throughout much of this week, the Dollar was offered lower as sellers re-gained control of near-term price action. But as we walked into CPI on Friday morning, a bit of strength had begun […]
USD/JPY Is Off The Highs – Forecast Oct. 16-20 2017
Dollar/yen extended its losses from the previous week but remains entrenched in range. Mixed signals from the Fed weighed on the pair. The upcoming elections in Japan also cause confusion. What’s next? A lot depends on further Fed-speak. USD/JPY fundamental movers Fed hesitance The FOMC meeting minutes did not point to a “no hike” in December but certainly […]
ECRI Weekly Leading Index: “Consensus Plays Catch Up To Our Global Growth Call”
Today’s release of the publicly available data from ECRI puts its Weekly Leading Index (WLI) at 145.2, up 1.2 from the previous week. Year-over-year the four-week moving average of the indicator is now at 3.62%, up from 3.17% last week. The WLI Growth indicator is now at 1.2, up from 0.7 the previous week. “Consensus […]
